Arkolith/Insider Trading/COGT/Form 4

Kearns Evan

Chief Legal OfficerCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Dec 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Grant(A)40K—$040K
Dec 17, 2025Grant(A)260K—$0300K
Dec 17, 2025Tax withholding(F)126K$39.45$5.0M174K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Grant(A)55K—$055K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-326772) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML